Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs)
$102.47
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | JNJ Avg Daily Volume: 6,281,400
Last Update: 07/22/14 - 4:03 PM EDT
Volume: 0
YTD Performance: 11.88%
Open: $0.00
Previous Close: $102.47
52 Week Range: $85.50 - $106.74
Oustanding Shares: 2,829,099,753
Market Cap: 289,190,576,752
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 5 5 5
Moderate Buy 3 3 3 3
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.27 2.19 2.19 2.19
Latest Dividend: 0.70
Latest Dividend Yield: 2.76%
Dividend Ex-Date: 08/22/14
Price Earnings Ratio: 18.72
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
18.72 18.90 28.87
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
2.29% 11.04% 53.58%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.10 0.16 0.05
Net Income 31.50 0.04 0.01
EPS 24.60 0.01 0.00
Earnings for JNJ:
EBITDA 23.06B
Revenue 71.31B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.44 $1.31 $5.90 $6.34
Number of Analysts 10 9 11 13
High Estimate $1.52 $1.39 $5.96 $6.48
Low Estimate $1.34 $1.22 $5.86 $6.23
Prior Year $1.36 $1.24 $5.52 $5.90
Growth Rate (Year over Year) 5.59% 5.82% 6.88% 7.43%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jul 22, 2014 | 10:52 AM EDT

These moves are all just random to that day, and nothing else.

By

Doug Kass

 | Jul 15, 2014 | 7:49 AM EDT
Where it began.

bearishJohnson & Johnson price target, estimates raised at Jefferies

Jul 14, 2014 | 8:13 AM EDT

JNJ upped its numbers, Jefferies said. Reflecting strong performance from Olysio. $114 price target and Hold rating. 

By

Doug Kass

 | Jul 14, 2014 | 8:06 AM EDT
Where it began.
By

Jim Cramer

 | Jul 3, 2014 | 11:10 AM EDT

I focus on the unemotional probabilities, as they win more often than not.

By

Sham Gad

 | Jun 25, 2014 | 2:00 PM EDT

Let's hear how the pros would finish that sentence.

By

Louis Grasso

 | May 12, 2014 | 1:30 PM EDT

Don't judge by previous examples.

By

Bret Jensen

 | May 12, 2014 | 11:00 AM EDT

The market is pitching some good large-caps to hit..

By

Jim Cramer

 | May 9, 2014 | 3:46 PM EDT

The rotation into blue-chip-like names is offsetting the tech exodus.

By

James "Rev Shark" DePorre

 | May 5, 2014 | 4:25 PM EDT

How will the summer play out if volume continues to dry up?

We are currently testing the key resistance decision in ICE. Do not consider an entry with...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Bef...
EA reported June revenue of $775 mlm vs. $714 est. much better than expected. EPS of $0.19...
BIDU still has some higher targets, but it's a good idea to TRAIL UP stops when you EXTEND...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.